Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca L Grosu

Showing results (111-120 of 174) with videos related to

Pageof 18
Sort By:
Cancers|March 6, 2021
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation TherapyMontserrat Carles, Tobias Fechter, Gianluca Radicioni, et al.
Frontiers in Oncology|May 31, 2021
Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology ReferenceSimon K B Spohn, Ilias Sachpazidis, Rolf Wiehle, et al.
Lab on a Chip|December 7, 2017
A deep conical agarose microwell array for adhesion independent three-dimensional cell culture and dynamic volume measurementAndreas R Thomsen, Christine Aldrian, Peter Bronsert, et al.
Frontiers in Oncology|December 17, 2020
Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI-A Correlation Study With Whole Mount Histopathological Information as ReferenceMaria Kramer, Simon K B Spohn, Selina Kiefer, et al.
Clinical and Translational Radiation Oncology|March 4, 2022
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiationAlexander Rühle, Anca-L Grosu, Nicole Wiedenmann, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spineMatthew D Cheney, Yen-Lin Chen, Ruth Lim, et al.
Physics and Imaging in Radiation Oncology|April 10, 2026
Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear acceleratorMarco Serpa, Rolf Wiehle, Thomas Rothe, et al.
Radiation Oncology (London, England)|April 14, 2018
The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancerConstantinos Zamboglou, Christina Marie Klein, Benedikt Thomann, et al.
The Journal of Urology|February 13, 2014
Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomographyCordula A Jilg, Wolfgang Schultze-Seemann, Vanessa Drendel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 8, 2013
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimensRalph A Bundschuh, Christina M Wendl, Gregor Weirich, et al.
Pageof 18

Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
Cancers|March 6, 2021
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation TherapyMontserrat Carles, Tobias Fechter, Gianluca Radicioni, et al.
Frontiers in Oncology|May 31, 2021
Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology ReferenceSimon K B Spohn, Ilias Sachpazidis, Rolf Wiehle, et al.
Lab on a Chip|December 7, 2017
A deep conical agarose microwell array for adhesion independent three-dimensional cell culture and dynamic volume measurementAndreas R Thomsen, Christine Aldrian, Peter Bronsert, et al.
Frontiers in Oncology|December 17, 2020
Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI-A Correlation Study With Whole Mount Histopathological Information as ReferenceMaria Kramer, Simon K B Spohn, Selina Kiefer, et al.
Clinical and Translational Radiation Oncology|March 4, 2022
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiationAlexander Rühle, Anca-L Grosu, Nicole Wiedenmann, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spineMatthew D Cheney, Yen-Lin Chen, Ruth Lim, et al.
Physics and Imaging in Radiation Oncology|April 10, 2026
Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear acceleratorMarco Serpa, Rolf Wiehle, Thomas Rothe, et al.
Radiation Oncology (London, England)|April 14, 2018
The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancerConstantinos Zamboglou, Christina Marie Klein, Benedikt Thomann, et al.
The Journal of Urology|February 13, 2014
Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomographyCordula A Jilg, Wolfgang Schultze-Seemann, Vanessa Drendel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 8, 2013
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimensRalph A Bundschuh, Christina M Wendl, Gregor Weirich, et al.
Pageof 18